Lipotes vexillifer (Yangtze River dolphin): 103090784
Help
Entry
103090784 CDS
T03090
Symbol
IL1B
Name
(RefSeq) interleukin-1 beta
KO
K04519
interleukin 1 beta
Organism
lve
Lipotes vexillifer (Yangtze River dolphin)
Pathway
lve01523
Antifolate resistance
lve04010
MAPK signaling pathway
lve04060
Cytokine-cytokine receptor interaction
lve04064
NF-kappa B signaling pathway
lve04217
Necroptosis
lve04380
Osteoclast differentiation
lve04620
Toll-like receptor signaling pathway
lve04621
NOD-like receptor signaling pathway
lve04623
Cytosolic DNA-sensing pathway
lve04625
C-type lectin receptor signaling pathway
lve04640
Hematopoietic cell lineage
lve04657
IL-17 signaling pathway
lve04659
Th17 cell differentiation
lve04668
TNF signaling pathway
lve04750
Inflammatory mediator regulation of TRP channels
lve04932
Non-alcoholic fatty liver disease
lve04933
AGE-RAGE signaling pathway in diabetic complications
lve04936
Alcoholic liver disease
lve04940
Type I diabetes mellitus
lve05010
Alzheimer disease
lve05020
Prion disease
lve05022
Pathways of neurodegeneration - multiple diseases
lve05132
Salmonella infection
lve05133
Pertussis
lve05134
Legionellosis
lve05135
Yersinia infection
lve05140
Leishmaniasis
lve05142
Chagas disease
lve05143
African trypanosomiasis
lve05144
Malaria
lve05146
Amoebiasis
lve05152
Tuberculosis
lve05162
Measles
lve05163
Human cytomegalovirus infection
lve05164
Influenza A
lve05168
Herpes simplex virus 1 infection
lve05171
Coronavirus disease - COVID-19
lve05321
Inflammatory bowel disease
lve05323
Rheumatoid arthritis
lve05332
Graft-versus-host disease
lve05417
Lipid and atherosclerosis
lve05418
Fluid shear stress and atherosclerosis
Brite
KEGG Orthology (KO) [BR:
lve00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
103090784 (IL1B)
04064 NF-kappa B signaling pathway
103090784 (IL1B)
04668 TNF signaling pathway
103090784 (IL1B)
09133 Signaling molecules and interaction
04060 Cytokine-cytokine receptor interaction
103090784 (IL1B)
09140 Cellular Processes
09143 Cell growth and death
04217 Necroptosis
103090784 (IL1B)
09150 Organismal Systems
09151 Immune system
04640 Hematopoietic cell lineage
103090784 (IL1B)
04620 Toll-like receptor signaling pathway
103090784 (IL1B)
04621 NOD-like receptor signaling pathway
103090784 (IL1B)
04623 Cytosolic DNA-sensing pathway
103090784 (IL1B)
04625 C-type lectin receptor signaling pathway
103090784 (IL1B)
04659 Th17 cell differentiation
103090784 (IL1B)
04657 IL-17 signaling pathway
103090784 (IL1B)
09157 Sensory system
04750 Inflammatory mediator regulation of TRP channels
103090784 (IL1B)
09158 Development and regeneration
04380 Osteoclast differentiation
103090784 (IL1B)
09160 Human Diseases
09172 Infectious disease: viral
05171 Coronavirus disease - COVID-19
103090784 (IL1B)
05164 Influenza A
103090784 (IL1B)
05162 Measles
103090784 (IL1B)
05168 Herpes simplex virus 1 infection
103090784 (IL1B)
05163 Human cytomegalovirus infection
103090784 (IL1B)
09171 Infectious disease: bacterial
05132 Salmonella infection
103090784 (IL1B)
05135 Yersinia infection
103090784 (IL1B)
05133 Pertussis
103090784 (IL1B)
05134 Legionellosis
103090784 (IL1B)
05152 Tuberculosis
103090784 (IL1B)
09174 Infectious disease: parasitic
05146 Amoebiasis
103090784 (IL1B)
05144 Malaria
103090784 (IL1B)
05140 Leishmaniasis
103090784 (IL1B)
05142 Chagas disease
103090784 (IL1B)
05143 African trypanosomiasis
103090784 (IL1B)
09163 Immune disease
05323 Rheumatoid arthritis
103090784 (IL1B)
05321 Inflammatory bowel disease
103090784 (IL1B)
05332 Graft-versus-host disease
103090784 (IL1B)
09164 Neurodegenerative disease
05010 Alzheimer disease
103090784 (IL1B)
05020 Prion disease
103090784 (IL1B)
05022 Pathways of neurodegeneration - multiple diseases
103090784 (IL1B)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
103090784 (IL1B)
05418 Fluid shear stress and atherosclerosis
103090784 (IL1B)
09167 Endocrine and metabolic disease
04940 Type I diabetes mellitus
103090784 (IL1B)
04936 Alcoholic liver disease
103090784 (IL1B)
04932 Non-alcoholic fatty liver disease
103090784 (IL1B)
04933 AGE-RAGE signaling pathway in diabetic complications
103090784 (IL1B)
09176 Drug resistance: antineoplastic
01523 Antifolate resistance
103090784 (IL1B)
09180 Brite Hierarchies
09183 Protein families: signaling and cellular processes
04052 Cytokines and neuropeptides [BR:
lve04052
]
103090784 (IL1B)
00536 Glycosaminoglycan binding proteins [BR:
lve00536
]
103090784 (IL1B)
Cytokines and neuropeptides [BR:
lve04052
]
Cytokines
Interleukins
103090784 (IL1B)
Glycosaminoglycan binding proteins [BR:
lve00536
]
Heparan sulfate / Heparin
Cytokines
103090784 (IL1B)
BRITE hierarchy
SSDB
Ortholog
Paralog
GFIT
Motif
Pfam:
IL1
IL1_propep
Motif
Other DBs
NCBI-GeneID:
103090784
NCBI-ProteinID:
XP_007446081
UniProt:
A0A340WC10
LinkDB
All DBs
Position
Unknown
AA seq
266 aa
AA seq
DB search
MATVPEPTNEVMDYYSDENDLLFEADSPKQMKCCVQHLDLSSTGDGSIHLQISHQLYNKS
FRKVVSVIVAMEKLQKVPCSQTFQDDGLRSILSLIFQEEPVIFETYDDDLLCDAVVQSLN
CKLQDRDQKSLVLASPCVLKALHLLERDVNREVVFCMSFVQGDESNDKIPVALGLKEKNL
YLSCVMKGDRPTLQLEEVDPKTYPKWKMEKRFVFNKTEIKNSVEFESALYPNWYISTSQA
EEKPIFLGRSKGGHDITDFTMEIISP
NT seq
801 nt
NT seq
+upstream
nt +downstream
nt
atggcaacggtacctgaacccaccaacgaagtgatggattactacagtgatgagaatgac
ctgttatttgaggctgacagccccaaacagatgaagtgctgcgtccaacacctggacctc
agctccacgggagatgggagcatccacctgcaaatctcccaccagctctacaacaagagc
ttcaggaaggtggtgtcggtcatcgtggccatggagaagctgcagaaggttccctgctca
cagaccttccaggatgatggcctgaggagcatcctttcactcatctttcaagaagagcct
gtcatctttgaaacgtacgatgatgatcttctgtgcgatgcggttgtgcagtcgctgaac
tgcaaactccaggacagagaccaaaaatccctggtgctggctagcccgtgtgtgctgaag
gctctccacctcctcgaacgggatgtgaaccgagaagtggttttctgcatgagcttcgtg
caaggagatgaaagtaacgacaagatacctgtggccttaggcctcaaggaaaagaatcta
tacctgtcttgtgtgatgaaaggcgataggcccaccctgcagctggaggaggtagacccc
aaaacttacccaaagtggaagatggaaaagcgattcgtcttcaacaagacagaaatcaag
aatagtgttgaatttgagtctgccctgtaccccaactggtacataagtacctctcaagca
gaagaaaagcccatcttcctaggacgttccaaaggcggccatgatataactgacttcacc
atggaaatcatctctccctaa
DBGET
integrated database retrieval system